The enhancement of tumour growth in VIRMA FL-overexpressing xenografts was supported by increased proliferation and angiogenesis as indicated by increased Ki67 and CD31 levels in the tumours, respectively (Fig. 3E–G). This evidence concerns the gene MKI67 and neoplasm.